APA
Attarbaschi A., Mann G., Panzer-Grümayer R., Röttgers S., Steiner M., König M., Csinady E., Dworzak M. N., Seidel M., Janousek D., Möricke A., Reichelt C., Harbott J., Schrappe M., Gadner H. & Haas O. A. (20080708). Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Attarbaschi Andishe, Mann Georg, Panzer-Grümayer Renate, Röttgers Silja, Steiner Manuel, König Margit, Csinady Eva, Dworzak Michael N, Seidel Markus, Janousek Dasa, Möricke Anja, Reichelt Carsten, Harbott Jochen, Schrappe Martin, Gadner Helmut and Haas Oskar A. 20080708. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Attarbaschi A., Mann G., Panzer-Grümayer R., Röttgers S., Steiner M., König M., Csinady E., Dworzak M. N., Seidel M., Janousek D., Möricke A., Reichelt C., Harbott J., Schrappe M., Gadner H. and Haas O. A. (20080708). Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Attarbaschi Andishe, Mann Georg, Panzer-Grümayer Renate, Röttgers Silja, Steiner Manuel, König Margit, Csinady Eva, Dworzak Michael N, Seidel Markus, Janousek Dasa, Möricke Anja, Reichelt Carsten, Harbott Jochen, Schrappe Martin, Gadner Helmut and Haas Oskar A. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20080708.